BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30919585)

  • 1. Circulating anti-glutamic acid decarboxylase-65 antibody titers are positively associated with the capacity of insulin secretion in acute-onset type 1 diabetes with short duration in a Japanese population.
    Yamamura S; Fukui T; Mori Y; Hayashi T; Yamamoto T; Ohara M; Fukase A; Sasamori H; Kobayashi T; Hirano T
    J Diabetes Investig; 2019 Nov; 10(6):1480-1489. PubMed ID: 30919585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic characteristics of people with type 1 diabetes who have discrepancies in titers of anti-glutamic acid decarboxylase antibody measured by radioimmunoassay and enzyme-linked immunosorbent assay.
    Takagi S; Miura J; Hoshina S; Uchigata Y; Babazono T
    J Diabetes Investig; 2020 Mar; 11(2):356-362. PubMed ID: 31267698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes.
    Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Ito Y; Hanafusa T
    J Diabetes Investig; 2020 Sep; 11(5):1181-1187. PubMed ID: 32175683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state.
    Oikawa Y; Tanaka H; Uchida J; Atsumi Y; Osawa M; Katsuki T; Kawai T; Shimada A
    Endocr J; 2017 Feb; 64(2):163-170. PubMed ID: 27760891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients.
    Liu J; Bian L; Ji L; Chen Y; Chen H; Gu Y; Ma B; Gu W; Xu X; Shi Y; Wang J; Zhu D; Sun Z; Ma J; Jin H; Shi X; Miao H; Xin B; Zhu Y; Zhang Z; Bu R; Xu L; Shi G; Tang W; Li W; Zhou D; Liang J; Cheng X; Shi B; Dong J; Hu J; Fang C; Zhong S; Yu W; Lu W; Wu C; Qian L; Yu J; Gao J; Fei X; Zhang Q; Wang X; Cui S; Cheng J; Xu N; Wang G; Han G; Xu C; Xie Y; An M; Zhang W; Wang Z; Cai Y; Fu Q; Fu Y; Zheng S; Yang F; Hu Q; Dai H; Jin Y; Zhang Z; Xu K; Li Y; Shen J; Zhou H; He W; Zheng X; Han X; Yu L; She J; Zhang M; Yang T
    Sci China Life Sci; 2016 Sep; 59(9):930-9. PubMed ID: 27225179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.
    Kawasaki E; Okada A; Uchida A; Fukuyama T; Sagara Y; Nakano Y; Tamai H; Tojikubo M; Koga N
    J Diabetes Investig; 2019 Jul; 10(4):990-996. PubMed ID: 30582775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ-specific autoantibodies in Chinese patients newly diagnosed with type 1 diabetes mellitus.
    Pan S; Wu T; Shi X; Xie Z; Huang G; Zhou Z
    Endocr J; 2020 Jul; 67(7):793-802. PubMed ID: 32295990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.
    Wenzlau JM; Walter M; Gardner TJ; Frisch LM; Yu L; Eisenbarth GS; Ziegler AG; Davidson HW; Hutton JC
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4712-9. PubMed ID: 20610599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of anti-glutamic acid decarboxylase antibody-positive fulminant type 1 diabetes.
    Saito D; Oikawa Y; Mizutani G; Inoue K; Hatano M; Inoue I; Noda M; Shimada A
    Endocr J; 2019 Apr; 66(4):329-336. PubMed ID: 30760658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of autoantibodies in type 1 diabetes mellitus pediatrics in Mazandaran, North of Iran.
    Zamanfar D; Aarabi M; Amini M; Monajati M
    J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1299-1305. PubMed ID: 32809953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a new enzyme-linked immunosorbent assay system for three islet cell autoantibodies in Japanese patients with acute-onset type 1 diabetes.
    Fukui T; Takehana N; Mori Y; Hiromura M; Terasaki M; Kushima H; Takada M; Tomoyasu M; Sato N; Hayashi T; Ohara M; Kikuchi T; Ito Y; Kobayashi T; Yamagishi SI
    Endocr J; 2022 Nov; 69(11):1343-1349. PubMed ID: 35753761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors affecting C-peptide level during the first year of type 1 diabetes in children].
    Zmysłowska A; Szadkowska A; Andrzejewski W; Wegner O; Wyka K; Młynarski W; Bodalski J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):103-11. PubMed ID: 15504313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of islet autoimmunity in the aetiology of different clinical subtypes of diabetes mellitus in young north Indians.
    Singh AK; Bhatia E; Dabadghao P; Bhatia V; Gellert SA; Colman PG
    Diabet Med; 2000 Apr; 17(4):275-80. PubMed ID: 10821293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different interaction of onset age and duration of type 1 diabetes on the dynamics of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8.
    Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Itoh Y; Hanafusa T
    J Diabetes Investig; 2021 Apr; 12(4):510-515. PubMed ID: 32696593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
    Zhu Y; Qian L; Liu Q; Zou J; Zhou Y; Yang T; Huang G; Zhou Z; Liu Y
    Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age.
    Borg H; Gottsäter A; Landin-Olsson M; Fernlund P; Sundkvist G
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3032-8. PubMed ID: 11443164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes.
    Takehana N; Fukui T; Mori Y; Hiromura M; Terasaki M; Ohara M; Takada M; Tomoyasu M; Ito Y; Kobayashi T; Yamagishi SI
    J Diabetes Investig; 2023 Jul; 14(7):856-863. PubMed ID: 37082800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies in relation to residual insulin secretion in children with IDDM.
    Ludvigsson J; Hellström S
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):81-9. PubMed ID: 9179462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actual condition survey regarding mismatch of measurements between radioimmunoassay and enzyme-linked immunosorbent assay tests for anti-glutamic acid decarboxylase antibody in real-world clinical practice.
    Oikawa Y; Kondo T; Shimada A; Seino Y; Kitaoka M
    J Diabetes Investig; 2019 May; 10(3):685-689. PubMed ID: 30307126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Normalization of High Glutamic Acid Decarboxylase Autoantibody Titers and Preserved Endogenous Insulin Secretion in a Patient with Diabetes Mellitus: A Case Report and Literature Review.
    Ohara N; Kaneko M; Furukawa T; Koike T; Sone H; Tanaka S; Kaneko K; Kamoi K
    Intern Med; 2016; 55(5):485-9. PubMed ID: 26935368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.